Journal article

Programmed cell death-1 inhibition in lymphoma

Eliza A Hawkes, Andrew Grigg, Geoff Chong

The Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2015

DOI: 10.1016/S1470-2045(15)70103-8

Grants

Funding Acknowledgements

EAH receives funding from the North Eastern Metropolitan Integrated Cancer Services. AG declares no competing interests. GC receives funding from Amgen, Novartis, and Astellas.

Citation metrics

36Web of Science
41Scopus

Keywords

Clinical Trials As Topic
Cd4(+) T-Cells
Humans
Hodgkin-Lymphoma
Antibodies, Monoclonal
Anti-Pd-1 Antibody
Pd-1 Expression
Lymphoma
Life Sciences & Biomedicine
Programmed Cell Death 1 Receptor
Science & Technology
Tumor Microenvironment
Clinical-Significance
Lymphoproliferative Disorders
Ligands
Oncology
Molecular Targeted Therapy
Ligand 1
Follicular Lymphoma
Prognostic-Factors
Signal Transduction